European membrane expertise to focus on new treatments for human diseases

A new 15 million Euro project led by the University of Leeds aims to find novel treatments for many human diseases by bringing together the leading European experts in membrane proteins.

The project – the European Drug Initiative for Channels and Transporters (EDICT) – will target about 80 proteins, which play an important role in human diseases as varied as diabetes, heart disease, neuropsychiatric disorders like epilepsy and depression, osteoporosis, stomach ulcers and cataracts.

Membrane proteins are key to every process in the human body, channelling ions or transporting chemicals and so are ideal targets for new treatments. Infections by pathogenic bacteria, yeasts and parasites also involve their own membrane proteins, which can be specific targets for development of new drugs and antibiotics.

The research is mainly funded by the European Commission, involves twenty-seven partners from twelve countries – including two Nobel Laureates - and is set to last four years.

Coordinating the project is Peter Henderson, Professor of Biochemistry and Molecular Biology from Leeds’ Faculty of Biological Sciences.

“Membrane proteins are seen by many as the next potential source of drug development, and so the EC is keen to fund research in this area,” he said. “However, they are difficult to study and are poorly understood, though the recent sequencing of the human and other genomes show they make up about one third of all proteins in all organisms, including humans.”

“At the moment, few groups of membrane proteins are being seriously investigated by the pharmaceutical industry, so this project will help to fill that gap. By bringing together the best scientists in this challenging field from all over Europe, we hope to make a real advance towards new treatments for key diseases.”

Industry has also seen the benefit of bringing such expertise together under one umbrella and working with the academics will be pharmaceutical giant AstraZeneca and a smaller company, Xention, which specialises in the discovery and development of novel and selective ion channel drugs.

The researchers include biologists, structural biologists, chemists and experts in the three key technologies: x-ray crystallography, nuclear magnetic resonance, and electron microscopy.

The team aims to map out the structure of the proteins, so they can identify compounds that could be developed as a treatment for these diseases. Where they have already mapped some structures, the team will have a head start and hope to make real advances towards new treatments.

Other researchers joining the project from Leeds include Professors Steve Baldwin and Carola Hunte from the Faculty of Biological Sciences and Professor Peter Johnson and Dr Colin Fishwick from the School of Chemistry. All are members of Leeds’ Astbury Centre, the leading interdisciplinary research centre in the UK studying how life works at an atomic level.

The two Nobel Laureates involved in the research are Director of the Medical Research Council’s Dunn Human Nutrition Unit in Cambridge, Professor Sir John Walker, who also holds an honorary doctorate from the University of Leeds, and Director of the Max Planck Institute for Biophysics in Frankfurt, Germany, Professor Hartmut Michel.

Source: University of Leeds

Related stories:

Computer game's high score could earn the Nobel Prize in medicine
Gamers have devoted countless years of collective brainpower to rescuing princesses or protecting the planet against alien invasions. This week researchers at the University of Washington will try to harness those finely honed skills to make medical discoveries, perhaps even finding a cure for HIV.
What horses can tell us now about the coming human flu pandemic
Stored safely in a freezer at Cornell's James A. Baker Institute for Animal Health are samples of the virus thought to be most like the one public health experts expect someday to afflict record numbers of the world's population. The virus was collected in 1973 during an outbreak of equine influenza at a Florida racetrack. Dorothy Holmes, an infectious disease specialist in Cornell's College of Veterinary Medicine, had obtained samples of the virus with the intention of using it to create nasal spray vaccines for horses.
Protein shows talent for improvisation
Radio and cable are not required for communication within and between living cells. Rather, signal transduction in cells is performed by a multitude of proteins. In order to transfer and interpret these signals correctly, activities of these proteins have to be precisely synchronized.
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
Researchers discover novel 'gene toggles' in world's top food crop
University of Delaware researchers, in collaboration with U.S. and international colleagues, have found a new type of molecule--a kind of “micro-switch”--that can turn off genes in rice, which is the primary source of food for more than half the world's population. The discovery is reported in the March 25 issue of the Proceedings of the National Academy of Sciences of the United States of America.
Scientists find a fingerprint of evolution across the human genome
The Human Genome Project revealed that only a small fraction of the 3 billion “letter” DNA code actually instructs cells to manufacture proteins, the workhorses of most life processes. This has raised the question of what the remaining part of the human genome does. How much of the rest performs other biological functions, and how much is merely residue of prior genetic events?
Rare genetic syndrome may hold key to cure for heat stroke
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell. The findings further suggest that antioxidants, like those currently being tested to protect the lungs of cystic fibrosis patients, may also protect those genetically prone to suffer heat stroke.
Self-Assembled Materials Form Mini Stem Cell Lab
Imagine having one polymer and one small molecule that instantly assemble into a flexible but strong sac in which you can grow human stem cells, creating a sort of miniature laboratory. And that sac, if used for cell therapy, could cloak the stem cells from the human body’s immune system and biodegrade upon arriving at its destination, releasing the stem cells to do their work.

News discussion:

Medicine & Health news